EYPT
EyePoint, Inc.Company Information
- Company Name
- EyePoint, Inc.
- CIK
- CIK0001314102
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- EYPT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3826
- SIC Description
- Laboratory Analytical Instruments
- Ticker
- EYPT
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-18
- Last sale
- 2026-06-30
- Shares purchased (TTM)
- 12,100
- Shares sold (TTM)
- 127,253
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 93,029,086
- Shares outstanding
- 86,543,000
- Ownership
- 107.49%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -63.43%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 110 | 78 | 102 | 75 | 71 | 85 | 100 | 80 | 91 | 271 | 281 | 133 | ||||||
| Marketable Securities Current | 70 | 145 | 204 | 129 | 185 | 233 | 271 | 174 | 189 | 28 | 50 | 3 | ||||||
| Accounts And Other Receivables Net Current | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 3 | 1 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 25 | 20 | 9 | 6 | 6 | 9 | 12 | 10 | 11 | 9 | 9 | ||||||
| Inventory Net | 2 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 4 | 4 | 4 | 5 | ||||||
| Assets Current | 189 | 250 | 329 | 216 | 265 | 327 | 383 | 269 | 295 | 318 | 345 | 150 | ||||||
| Property Plant And Equipment Net | 10 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 5 | 4 | ||||||
| Operating Lease Right Of Use Asset | 20 | 20 | 20 | 21 | 21 | 22 | 21 | 21 | 22 | 5 | 5 | 5 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 9 | 9 | 6 | 6 | 6 | 6 | 6 | 2 | - | - | 0 | - | ||||||
| Assets | 228 | 288 | 364 | 252 | 301 | 363 | 418 | 301 | 324 | 329 | 355 | 160 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 17 | 19 | 10 | 10 | 20 | 16 | 12 | 7 | 14 | 7 | 7 | 10 | ||||||
| Accrued Liabilities Current | 22 | 16 | 24 | 18 | 11 | 18 | 18 | 14 | 13 | 16 | 18 | 13 | ||||||
| Deferred Revenue Current | - | - | 0 | - | 0 | 5 | 18 | 26 | 33 | 38 | 39 | 40 | ||||||
| Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Liabilities Current | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 42 | 37 | 37 | 30 | 33 | 42 | 49 | 49 | 62 | 63 | 63 | 64 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Deferred Revenue Noncurrent | - | - | 0 | 0 | 0 | 0 | 11 | 11 | 12 | 12 | 21 | 32 | ||||||
| Operating Lease Liability Noncurrent | 20 | 20 | 21 | 21 | 22 | 22 | 22 | 22 | 22 | 5 | 5 | 5 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | ||||||
| Liabilities | 62 | 58 | 58 | 52 | 55 | 64 | 82 | 82 | 96 | 79 | 89 | 101 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,450 | 1,419 | 1,410 | 1,237 | 1,223 | 1,216 | 1,208 | 1,049 | 1,030 | 1,020 | 1,008 | 786 | ||||||
| Retained Earnings Accumulated Deficit | -1,284 | -1,190 | -1,105 | -1,037 | -978 | -918 | -873 | -832 | -802 | -771 | -742 | -728 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Stockholders Equity | 166 | 230 | 306 | 200 | 246 | 298 | 337 | 219 | 228 | 250 | 266 | 59 | ||||||
| Liabilities And Stockholders Equity | 228 | 288 | 364 | 252 | 301 | 363 | 418 | 301 | 324 | 329 | 355 | 160 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 85 | 83 | 83 | 70 | 69 | 69 | 68 | 54 | 52 | 50 | 49 | 35 | ||||||
| Shares Outstanding | 85 | 83 | 83 | 70 | 69 | 69 | 68 | 54 | 52 | 50 | 49 | 35 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEyePoint, Inc. (EYPT) — SEC Financial Statements & Analysis
EyePoint, Inc. (EYPT) is a laboratory analytical instruments company, incorporated in DE. EyePoint, Inc. trades on Nasdaq as: EYPT. EyePoint, Inc. (EYPT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, EyePoint, Inc. carries a market cap of $1.24B, a P/E ratio of -4.04x, a P/B ratio of 7.44x, a P/S ratio of 443.89x, an enterprise value of $1.13B, and an EV/EBITDA multiple of -3.58x. On profitability, it posts a gross margin of 93.29%, an operating margin of -11369.30%, a net margin of -10998.67%, a Return on Equity (ROE) of -148.70%, a Return on Assets (ROA) of -115.86%, and a Return on Invested Capital (ROIC) of -273.61%. Per share, it reports EPS of $-3.54, diluted EPS of $-3.54, free cash flow per share of $-3.13, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -94.63% year-over-year, net income growth of 74.84% year-over-year, and EPS growth of 41.27% year-over-year. On the balance sheet, it maintains a current ratio of 4.50x, a quick ratio of 4.30x, working capital of $146.87M, a debt-to-equity ratio of 0.37x, a debt ratio of 0.27, an interest coverage ratio of -199.62x, free cash flow of $-271.28M (TTM), and net debt of $-110.61M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.24B
- P/E TTM
- -4.04x
- EPS TTM
- $-3.54
- P/B TTM
- 7.44x
- ROE TTM
- -148.70%
- ROA TTM
- -115.86%
- Debt To Equity
- 0.37x
- Free Cash Flow TTM
- $-271.28M
- Net Revenue TTM Growth 1Y
- -94.63%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is EyePoint, Inc. in?
EyePoint, Inc. (EYPT) operates in the Laboratory Analytical Instruments industry.
What exchange does EYPT trade on?
EyePoint, Inc. (EYPT) trades on the Nasdaq.
Where is EyePoint, Inc. incorporated?
EyePoint, Inc. is incorporated in DE.
When was EyePoint, Inc. (EYPT)'s most recent SEC filing?
EyePoint, Inc. (EYPT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is EYPT's market cap?
EyePoint, Inc. (EYPT) has a market capitalization of $1.24B as of 2026-06-30.
What is EYPT's EPS (earnings per share)?
EyePoint, Inc. (EYPT)'s trailing twelve month EPS is $-3.54 as of 2026-06-30.
What is EYPT's ROE (return on equity)?
EyePoint, Inc. (EYPT)'s trailing twelve month Return on Equity (ROE) is -148.70% as of 2026-06-30.
What is EYPT's ROA (return on assets)?
EyePoint, Inc. (EYPT)'s trailing twelve month Return on Assets (ROA) is -115.86% as of 2026-06-30.
What is EYPT's ROIC (return on invested capital)?
EyePoint, Inc. (EYPT)'s trailing twelve month Return on Invested Capital (ROIC) is -273.61% as of 2026-06-30.
What is EYPT's EV/EBITDA?
EyePoint, Inc. (EYPT)'s trailing twelve month EV/EBITDA is -3.58x as of 2026-06-30.